Back to All Events

Panel Discussion: Creating Awareness Amongst Decision-Makers on Local & Global Disparities in Liquid Biopsy Research and Practice to Shape an Inclusive Future for Understudied Diseases

  • Liquid Biopsy for Precision Oncology Summit 2024 San Diego, CA United States (map)

In this discussion at the 2024 Liquid Biopsy for Precision Oncology Summit, panelists from MEI Pharma, Johnson& Johnson, BLOODPAC, and University of Michigan will address the following topics:

  • How is the potential and utilization of liquid biopsies for new indications benefiting patients from diverse backgrounds?

  • Why are certain populations underrepresented in studies harnessing liquid biopsy?

  • What is being done to overcome the historical disparities in liquid biopsy trials?

  • How can the ED&I challenges be overcome by global and cross-sector collaboration for liquid biopsy research?

Previous
February 29

Harnessing Liquid Biopsies to Transform Cancer Treatment Selection, Monitoring & Early Detection and Empower Precision Treatments

Next
March 28

Talk: Creating consensus on a lexicon for cancer early detection and screening liquid biopsy tests